Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Papadopoulou

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Japanese Journal of Cancer Research : Gann|August 1, 1992
Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea's toxicity in vitro by two new bioreductive agentsM V Papadopoulou, A Mainwaring, W D Bloomer
Journal of Experimental Therapeutics & Oncology|October 10, 2006
Potentiation of alkylating agents by NLCQ-1 or TPZ in vitro and in vivoMaria V Papadopoulou, Xinhai Ji, William D Bloomer
In Vivo (Athens, Greece)|January 1, 1996
THNLA-1: a DNA-targeted bioreductive agent as chemosensitizer in vitro and in vivoM V Papadopoulou, M Ji, W D Bloomer
International Journal of Pharmaceutics|January 22, 2008
Development of a reaction-limited model of dissolution: application to official dissolution tests experimentsA Dokoumetzidis, V Papadopoulou, G Valsami, et al.
Basic & Clinical Pharmacology & Toxicology|January 6, 2011
Hypoxia-dependent retinal toxicity of NLCQ-1 (NSC 709257) in BALB/c mice. Comparison with tirapazamineMaria V Papadopoulou, Ming Ji, William D Bloomer
International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
NLCQ-1, a novel hypoxic cytotoxin: potentiation of melphalan, cisDDP and cyclophosphamide in vivoM V Papadopoulou, M Ji, W D Bloomer
Anticancer Research|November 11, 2006
Novel fluorinated hypoxia-targeted compounds as Non-invasive probes for measuring tumor-hypoxia by 19F-magnetic resonance spectroscopy (19F-MRS)Maria V Papadopoulou, Ming Ji, William D Bloomer
The British Journal of Cancer. Supplement|July 1, 1996
THNLA-1 as radio/chemosensitiser of EMT-6 tumours in miceM V Papadopoulou, M Ji, W D Bloomer
Anticancer Research|September 15, 2005
NLCQ-1 (NSC 709257) in combination with radiation against human glioma U251 xenograftsMaria V Papadopoulou, William D Bloomer, Melinda G Hollingshead
International Journal of Antimicrobial Agents|March 24, 2007
NLCQ-1 and NLCQ-2, two new agents with activity against dormant Mycobacterium tuberculosisMaria V Papadopoulou, William D Bloomer, Michael R McNeil
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Japanese Journal of Cancer Research : Gann|August 1, 1992
Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea's toxicity in vitro by two new bioreductive agentsM V Papadopoulou, A Mainwaring, W D Bloomer
Journal of Experimental Therapeutics & Oncology|October 10, 2006
Potentiation of alkylating agents by NLCQ-1 or TPZ in vitro and in vivoMaria V Papadopoulou, Xinhai Ji, William D Bloomer
In Vivo (Athens, Greece)|January 1, 1996
THNLA-1: a DNA-targeted bioreductive agent as chemosensitizer in vitro and in vivoM V Papadopoulou, M Ji, W D Bloomer
International Journal of Pharmaceutics|January 22, 2008
Development of a reaction-limited model of dissolution: application to official dissolution tests experimentsA Dokoumetzidis, V Papadopoulou, G Valsami, et al.
Basic & Clinical Pharmacology & Toxicology|January 6, 2011
Hypoxia-dependent retinal toxicity of NLCQ-1 (NSC 709257) in BALB/c mice. Comparison with tirapazamineMaria V Papadopoulou, Ming Ji, William D Bloomer
International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
NLCQ-1, a novel hypoxic cytotoxin: potentiation of melphalan, cisDDP and cyclophosphamide in vivoM V Papadopoulou, M Ji, W D Bloomer
Anticancer Research|November 11, 2006
Novel fluorinated hypoxia-targeted compounds as Non-invasive probes for measuring tumor-hypoxia by 19F-magnetic resonance spectroscopy (19F-MRS)Maria V Papadopoulou, Ming Ji, William D Bloomer
The British Journal of Cancer. Supplement|July 1, 1996
THNLA-1 as radio/chemosensitiser of EMT-6 tumours in miceM V Papadopoulou, M Ji, W D Bloomer
Anticancer Research|September 15, 2005
NLCQ-1 (NSC 709257) in combination with radiation against human glioma U251 xenograftsMaria V Papadopoulou, William D Bloomer, Melinda G Hollingshead
International Journal of Antimicrobial Agents|March 24, 2007
NLCQ-1 and NLCQ-2, two new agents with activity against dormant Mycobacterium tuberculosisMaria V Papadopoulou, William D Bloomer, Michael R McNeil
Pageof 8